✦ LIBER ✦

A 4 years follow up in children with moderate/severe asthma after discontinuation of 1 year treatment with omalizumab

✍ Scribed by C.E. Baena-Cagnani; A. Teijeiro; H. Badellino; M.E. Zernotti; G.W. Canonica; V.H. Croce; R. Baena-Cagnani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reasons for Discontinuation of Omalizuma

✍ SHEINKOPF, L; RAFI, A; DO, L; KLAUSTERMEYER, W; KATZ, R 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 49 KB

EIGHT YEARS LATER IN BIRMINGHAM: a follo

✍ SMITH, BERYL ;PHILLIPS, CHARLES J. 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 551 KB

Safety Of Omalizumab Treatment In Childr

✍ IYENGAR, S; HOYTE, E; LOZA, A; BONACCORSO, S; UMETSU, D; NADEAU, K 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Randomised placebo-controlled trial of i

✍ MJA Tasche; JC van der Wouden; JHJM Uijen; BP Ponsioen; RMD Bernsen; LWA van Sui 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 204 KB

Clinical outcome in patients with obsess

✍ Andreas Kordon; K. G. Kahl; A. Broocks; U. Voderholzer; H. Rasche–Räuchle; F. Ho 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 202 KB

Treatment with trastuzumab for 1 year af

✍ Luca Gianni; Urania Dafni; Richard D Gelber; Evandro Azambuja; Susanne Muehlbaue 📂 Article 📅 2011 🏛 The Lancet 🌐 English ⚖ 322 KB